Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dweck, M.
Right arrow Articles by Francis, C M.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical aspects of silent myocardial ischaemia: with particular reference to diabetes mellitus

Marc Dweck

Department of Cardiology, Victoria Hospital, Kirkcaldy, UK

Ian W Campbell

University of St Andrews, St Andrews, UK

Douglas Miller

University of St Andrews, St Andrews, UK

C Mark Francis

Department of Cardiology, Victoria Hospital, Kirkcaldy, UK, mark.francis{at}faht.scot.nhs.uk

Silent ischaemia is a common, under-recognised condition that is associated with an adverse prognosis. It is a marker of significant underlying coronary artery disease and therefore of future cardiovascular events. It is more prevalent in the diabetic population and diagnosis is usually made by a positive exercise tolerance test, positive myocardial perfusion scan or stress echo. The basis of treatment, in diabetic and non-diabetic subjects, is risk factor modification and coronary revascularisation of prognostically important coronary disease. Diabetic patients should receive risk factor modification even in the absence of ischaemia. Detection of silent ischaemia allows patients with prognostically important disease to be offered further treatment. The difficulty lies in deciding who to investigate further for this surreptitious disorder. The following clinical markers are of predictive use in this regard: electrocardiographic changes; erectile dysfunction; peripheral vascular disease and cardiac autonomic neuropathy. Their presence should prompt further investigation for silent ischaemia. Conventional risk factors and breathlessness on exertion may also be helpful. We have proposed an algorithm for the detection, investigation and management of silent myocardial ischaemia in diabetic patients.

Key Words: diabetes • infarction • myocardial ischaemia • silent.

The British Journal of Diabetes & Vascular Disease, Vol. 9, No. 3, 110-116 (2009)
DOI: 10.1177/1474651409105249
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
S. Stern and S. Sclarowsky
The ECG in Diabetes Mellitus
Circulation, October 20, 2009; 120(16): 1633 - 1636.
[Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
M. Dweck, D. Miller, I. W Campbell, and C M. Francis
Review: Mechanisms of silent myocardial ischaemia: with particular reference to diabetes mellitus
The British Journal of Diabetes & Vascular Disease, May 1, 2009; 9(3): 99 - 102.
[Abstract] [PDF]